EBIT: Income before interest and taxes.
Opus Genetics, Inc. (IRD) had EBIT of $-8.91M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$2.88M |
|
$-7.42M |
|
-- |
|
$2.88M |
|
$11.79M |
|
$-8.91M |
|
$1.49M |
|
$-7.42M |
|
$-7.42M |
|
$-7.42M |
|
$-7.42M |
|
$-7.42M |
|
$-7.42M |
|
|
EBIT |
$-8.91M |
$-8.89M |
|
63.38M |
|
63.38M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$38.44M |
|
$0.23M |
|
$0.23M |
|
$38.66M |
|
$20.19M |
|
$1.00M |
|
$1.00M |
|
$21.19M |
|
$17.47M |
|
$17.47M |
|
$17.47M |
|
59.91M |
|
| Cash Flow Statement Financials | |
$-19.26M |
|
-- |
|
$21.37M |
|
$30.32M |
|
$32.43M |
|
$2.11M |
|
$1.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.90 |
|
-- |
|
-- |
|
0.05 |
|
0.06 |
|
100.00% |
|
-309.02% |
|
-309.02% |
|
-- |
|
-257.46% |
|
-257.46% |
|
$-19.26M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
0.85 |
|
106.14 |
|
-42.47% |
|
-42.47% |
|
-19.19% |
|
-40.17% |
|
$0.29 |
|
$-0.30 |
|
$-0.30 |
|